chrisvoncsefalvay/vaers-outcomes huggingface dataset:
shingles; Information has been received from a lawyer regarding a case in litigation concerning a unknown age female patient. The patient's historical condition, concomitant medications and drug reactions or allergies were not reported.  On an unspecified date in 2016 , the patient was vaccinated with zoster vaccine live(ZOSTAVAX)(strength, dose, frequency, route, lot # and expiration date were not reported) for the long-term prevention of shingles and zoster-related condition.  On an unknown date, the patient was treated for shingles. The event caused the patient hospitalization. As a direct and proximate result of Plaintiff's use of the zoster vaccine live(ZOSTAVAX) vaccine, Plaintiff has and will continue suffer ongoing injuries, including but not limited to: mental and physical pain and suffering; medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs include care for hospitalization, physician care, monitoring, treatment, medications, and supplies; diminished capacity for the enjoyment of life; diminished quality of life; increased risk of premature death, aggravation of preexisting conditions and activation of latent conditions; and other losses and damages; and will continue to suffer such losses, and damages in the future. The outcome of event was unknown. The reporter considered herpes zoster to be related to zoster vaccine live(ZOSTAVAX).
Patient  presented to urgent care with overall full body weakness, poor appetite, and nausea/vomiting. Patient had intermittent fevers, chills, and unable to walk due to weakness since two days after shingles vaccine.  Patient's with 7-9/10 pain in left flank near kidney level.
Fainted in classroom, BP = 160/100, flushed, elevated legs, HR = 111. Stabilized by 12:20 PM.
Began having mid to lower back discomfort on 4/7/01 about 14:00. Continued with joint (knee and right hip) and general muscle aches. On 4/10/01 about 12:00, noted rash that was flat and pint to red on face and neck. Temperature was 99.5F. On 4/11/01, rash to arms and hands (non-palmer surface) and temperature was 100F. On 4/12/01, rash also on chest and back. Noted swollen glands behind ears and back of neck on right side more than left side. On 4/12/01, states feeling some better today, but "itchy". Some pain in right ear today.
On day 14 circular swollen rash with vaccinator  finger imprint bruises above and below vaccine injection site. Right side lymph nodes swollen, neck pain, headache.
Elevated blood pressure (155/95); decrease in heart rate (55); Face & tongue went numb; Face & tongue went numb; Residual ringing in left ear; This is a spontaneous report from a contactable physician, the patient. A 39-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), intramuscularly in the left arm on 22Dec2020 at 16:00 (at the age of 39-years-old) as a single dose for COVID-19 immunization. Medical history included seasonal allergies and allergies/asthma, from unknown dates and unknown if ongoing. The patient was not pregnant at the time of vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included cetirizine hydrochloride (ZYRTEC) and montelukast sodium (SINGULAIR). The patient did not receive any other vaccines within 4 weeks prior to the vaccination. On 22Dec2020 at 16:00, the patient experienced elevated blood pressure of 155/95 (normal was 110/60), a decrease in heart rate which was 55, face and tongue went numb and residual ringing in the left ear. The patient was treated for the events with diphenhydramine (BENADRYL). Since the vaccination, the patient had not been tested for COVID-19. The outcome of the events elevated blood pressure of 155/95 (normal was 110/60), a decrease in heart rate which was 55, face and tongue went numb and residual ringing in the left ear was resolved with sequel.   Information on lot/batch number has been requested.
Hives/rash developed within 15 minutes, was injected with 25mg of Benadryl. Another 15 minutes or so later it had become hard to swallow, I was given another 25mg dose of Benadryl. After the second dose  it became hard to breathe, started coughing and chest started to hurt. I didn?t realize but had broke out in sweat. Nurse checked my eyes. Called paramedics and had epi pen ready. I thought a third dose of Benadryl had been administered but that I am not certain of. Blood pressure was higher than my usual but still considered normal (113/82 I think?) pulse was 120 something, at rest I am usually at 70. I became lightheaded. Paramedics did an ekg, it was normal. They monitored me while I stabilized. Was released when pulse was in the 80?s range. Residual chest pain after. 8 days after vaccination I broke out in sweat and became nauseous. Vomited. I then noticed below the vaccination injection (still bruised) and around where last dose of Benadryl was injected there was a large red welp, hot to the touch. The heat eventually went away but the welp remained a few days. 11 days after vaccination is when the cluster headache appeared. Shortness of breath was noticeable on day 12. Day 14 fever and nasal congestion with slight irritation in throat, occasional cough. Day 15 sore throat, coughing progressed (non productive) in to fits that led to vomiting. It is day 18 and shortness of breath is present at rest, chest pain, rash near injection site and bruise is still present. Temp has been low grade fever, hadn?t gone above 100. Normal is 96.9/97.1 for me. Oddly day 13 (the day before fever became present) my temp was lower than usual 95.6/95.7 yet I wasn?t cold.
Thursday I felt even worse and had a hard time getting out of bed. I had body aches, headache, felt weak, nauseous and couldn?t eat anything.
Patient explained that she has a mild injection site reaction on her left arm. I explained to her this is normal with shingrix. However, the patient said on her right shoulder she had painful hives around her bra line. I told her to take benadryl and call her MD.
Information has been received from a physician concerning a 4 year old male with Chiari malformation and a history of recurrent febrile convulsions who on 22-APR-2002 was vaccinated with a dose of varicella virus vaccine live (Oka/Merck) (lot # 640156/0978L). There was no concomitant medication. On 11-AUG-2005 the patient experienced varicella lesions. He presented to the office on 14-AUG-2005 with 30 varicella lesions, 20 of these lesions were vesicular and 10 were maculopapular. The patient did not have a fever. Treatment included diphenhydramine hcl (BENADRYL) for the itching. No other information was available. No product quality complaint was involved. Additional information has been requested.
Guillain Barre Syndrome. Of note, questionable parent with questionable distant history of GBS after vaccine.    02/11/05 Received Discharge summary of 11/22-11/29/2004. FINAL DX: Guillain Barre syndrome records reveal patient experienced progressive weakness begining late Oct.  Developed foot drop & had falls w/elbow fx.  When seen in Ortho clinic for elbow fx, weakness of LEs noted & pt admitted.  Neuro consult done. Reflexes decreased.  Tx w/IVIG & steroids.  Minimal improvement.  Transferred to inpatient rehab.  Follow up 01/20/05: Patient has recovered from adverse event. 60 Day Follow up: severe leg weakness, requires walker.
Patient developed racing heart rate ~18 hours after his vaccine at 5 am the next morning. The racing heart rate was associated with L sided jaw pain. His family gave him 81 mg aspirin x 2 but later that day his heart racing was continuing and he developed mild chest pain, prompting him to go to ED.
Vaccine in eyes; A spontaneous report was received from a pharmacist concerning a 30-year-old female patient, who got Moderna's COVID-19 vaccine (mRNA-1273) in her eyes.   The patient's medical history was not provided. Concomitant medication use was not provided by reporter.   On an unknown date, prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 (lot number unknown) for COVID-19 infection prophylaxis.   The patient got mRNA-1273 vaccine in her eyes (Accidental contact of product with eye).   No treatment information was provided.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome was considered resolved for event.; Sender's Comments: This report refers to a case of accidental exposure to product for mRNA-1273 with no associated AEs.
2nd dose I felt ok that day the shot was given. However the next day I had constant chills for the entire day.  I just couldn't warm up spent day in a full length jacket blankets and sat next to heater. finally about 12 hours later I finally was able to feel warm, chills stopped.
Rash starting on stomach and spreading over days to chest, upper and lower back, upper arms, thighs. Rash started as hives then changed to red bumps resembling chicken pocks. Very itchy. Some relief from itching with pseudoephedrine.
Expired Moderna Covid-19 Vaccine Administered; The vaccine was moved from freezer to refrigerator the day before administration.; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT STORAGE ERROR (The vaccine was moved from freezer to refrigerator the day before administration.) and EXPIRED PRODUCT ADMINISTERED (Expired Moderna Covid-19 Vaccine Administered) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038C21A.) for COVID-19 vaccination.     No Medical History information was reported.    On 29-Oct-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Oct-2021, the patient experienced PRODUCT STORAGE ERROR (The vaccine was moved from freezer to refrigerator the day before administration.). On 29-Oct-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired Moderna Covid-19 Vaccine Administered). On 29-Oct-2021, PRODUCT STORAGE ERROR (The vaccine was moved from freezer to refrigerator the day before administration.) outcome was unknown and EXPIRED PRODUCT ADMINISTERED (Expired Moderna Covid-19 Vaccine Administered) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant and treatment information was provided.
Vomiting, 3 times between 13:50 pm and 19:30 pm.
Sore arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Sore arm) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 043B21A) for COVID-19 vaccination.     Concurrent medical conditions included Menopause, Tinnitus (Had history of tinnitus,when blood pressure was elevated and feels a pulse sensation in ears.) and Blood pressure high. Concomitant products included CALCIUM for Menopause.    On 15-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PAIN (Sore arm). At the time of the report, VACCINATION SITE PAIN (Sore arm) had resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       Concomitant medications also included fiber supplement (to help with menopause). Treatment included Hydration.   This case was linked to MOD-2021-396702, MOD-2021-396724 (Patient Link).
Information has been received from a health professional concerning a 4 month old Hispanic male with no medical history or allergies who on 18-SEP-2006 at 5:50 PM was vaccinated with a 2 mL PO first dose of rotavirus reassortant vaccine live (human-bovine) (lot # 654970/0777F). There was no illness at the time of vaccination. There was no adverse event and the patient did well. Medical attention was not sought. No laboratory tests were performed. There was no product quality complaint involved. No further information is available.
No additional AE reported; PROQUAD was administered to a 19 year old patient; This spontaneous report was received from a medical assistant referring to a 19-year-old patient. The patient's medical and concurrent conditions were not reported. Concomitant therapies were not provided.  On 04-MAR-2022, the patient was vaccinated with measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) subcutaneous injection (lot #U024510 with an expiration date on 02-FEB-2023), administered for prophylaxis (strength, dose and route of administration were not provided) (product administered to patient of inappropriate age).  No additional adverse events were reported.
large swelling, erythema, & induration @ inj site that lasted 4-5 days;felt weak all over for 10 days;
Patient called office with complaints of feeling feverish,dizziness,headache, and nausea. Onset 24-28 hours after injection. Symptoms lasted approx 24 hours. Patient used Tylenol with good effect.
TICK BITES; PRESCRIBED FLUMIST FOR ADULT PATIENT; UPSET STOMACH; A spontaneous report has been received from a consumer. The report concerns a female patient (age 44 years, height 65 in, weight 138 lb).    No medical history was reported.  Concomitant medication included acetylsalicylic acid.     Patient mentioned successfully being administered Flumist seasonally on a yearly basis and most recent received FluMist Quadrivalent (influenza virus vaccine live, intranasal) 0.2 ml once/single administration, via nasal route, for immunization during OCT-2019. Patient had not received FluMist in 2020.    The patient started treatment with Metoprolol (metoprolol) (batch number(s) unknown) 0.25 mg daily on an unknown date for blood pressure.     The report described a medication error for FluMist Quadrivalent. The reported term was "prescribed FluMist for adult patient" (Preferred term: Product prescribing error).     During JUL-2020, the patient experienced upset stomach (preferred term: Abdominal discomfort). On an unknown date, the patient experienced tick bites (preferred term: Arthropod bite).     Treatment with Metoprolol (metoprolol) was not changed.     At the time of reporting, the event of upset stomach was ongoing. The outcome of the event(s) of tick bites and prescribed flumist for adult patient was unknown.     The events were considered non-serious.     The reporter considered the following event(s) unrelated to treatment with FluMist Quadrivalent (influenza virus vaccine live, intranasal): upset stomach.
A rash that hurts; Itchy; Headaches; Pain on arm; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Headaches), PAIN IN EXTREMITY (Pain on arm), RASH (A rash that hurts) and PRURITUS (Itchy) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Jan-2021, the patient experienced HEADACHE (Headaches) and PAIN IN EXTREMITY (Pain on arm). On 26-Jan-2021, the patient experienced RASH (A rash that hurts) and PRURITUS (Itchy). The patient was treated with HYDROCORTISONE (CORTISONE [HYDROCORTISONE]) (other) at an unspecified dose and frequency and IBUPROFEN (ADVIL [IBUPROFEN]) at an unspecified dose and frequency. On 21-Jan-2021, HEADACHE (Headaches) and PAIN IN EXTREMITY (Pain on arm) had resolved. At the time of the report, RASH (A rash that hurts) and PRURITUS (Itchy) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.    Treatment for the events included Cortisone cream "right on the muscle" and Advil.   Reporter did not allow further contact
Initial medication error report received on 04 October 2013 from a nurse. A 3 years old unknown patients whose gender, medical history and concomitant medications were not reported, received a dose of FLUZONE (route, lot number and site of vaccination was not reported) on an unspecified date. Nurse reported that she gave 7 children over the age of 3 0.25ml instead of 0.5ml. List of documents held by sender: none.
Patient was in office on 04/24/2023, she was administered vaccines ordered, MMR and Varicella, I grabbed what I thought was MMR vaccine from the freezer in the container labeled MMR and continued to administer vaccine on left arm, when I entered the Lot # W023870 the vaccine pulled up as MMRV (Proquad) When I went to investigate I and other MA found that the container was overlapped with other container reading  MMR and MMRV. Patient was given MMRV and Varicella on same day.
10/31/2022 I had cold symptoms. I kept feeling bad. I went to my doctor on  11/15/2022. I was given medications for sinuses. I did not get better. I had another appointment on 11/29/22. I was given sinus medication and inhalers. On 12/8/22, I saw my doctor again because I was not getting better. She tested me for RSV and it was positive. I was started on an antibiotic. I then got better.
This case was reported by a other health professional via call center representative and described the occurrence of rash in a 68-year-old female patient who received SHINGRIX for prophylaxis. On 17th July 2018, the patient received the 1st dose of SHINGRIX. On 17th July 2018, less than a day after receiving SHINGRIX, the patient experienced rash and pruritus. On an unknown date, the outcome of the rash and pruritus were not recovered/not resolved. It was unknown if the reporter considered the rash and pruritus to be related to SHINGRIX. Additional details were provided as follows: The case was reported by the medical assistant. The patient was administered SHINGRIX in the left arm. The patient experienced a rash on her left deltoid area which was 19 cm in length and 8 cm in width, associated with itching. It had gotten worse since the day of getting the vaccine. No further details were provided.
I had my 3rd covid shot yesterday; I had my 3rd covid shot yesterday; I have a problem with my left lung; This is a spontaneous report from a contactable consumer or other non-hcp (Patient). A male patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: solution for injection; Batch/Lot Number: Unknown, Expiration date: Unknown) via an unspecified route of administration on 25Aug2021 at 14:30 as dose 3 (booster), single for COVID-19 immunization. The patient medical history and concomitant medications were not reported. Historical vaccine included first and second dose of BNT162B2 administered on an unspecified date for COVID-19 immunization. On an unspecified date in 2021 the patient experienced he had a problem with his left lung. The patient underwent lab tests and procedures on an unspecified date which included blood test: unknown results, polymerase chain reaction: unknown results, SARS-CoV-2 test: unknown results. It was reported that "the patient had his 3rd COVID shot yesterday. Question asked "if there is antibody testing available to check his immunity (regarding his 3rd dose). he had a blood test done previously an antigen and PCR test they were designed that he had powerful response to the virus. They said his immune system reacted and he had good protection; had enough protection as a result of the pfizer vaccine." "He asked if the 3rd shot the same dose." Caller stated, "he had a problem with his left lung. He had his 3rd COVID shot yesterday at 2:30 in the afternoon and today at 4pm he took 1 Celebrex pill. He took a pain killer 26 hours after his shot will that negate the covid shot he got. He asked if it would negate the antiviral in terms of protection. He also asked if he need to take another shot." Therapeutic measures were taken as a result of he had a problem with his left lung. The clinical outcome of the event was unknown.  The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.
Vaccinated 1/23/08, On 1/25 ct noted "Bruising, redness, hot to touch, sore, itching welts" Sx began at location of TDAP and spread down "shoulder to elbow". (TDAP given at prox. location on L delt; hep A given 2 inches distal on L deltoid).  On 1/26 Ct went to ER and was given "antihistamines, ibuprofen, Keflex, and anti-itching cream". On 1/30/08 sx had resolved to "size of quarter" and on 2/19/08, ct reports sx resoloved had competely 2 weeks post vaccination.
Pt had swelling around injection site and then started having chills and pain. She went to the ER and was given Abx, steroids and EPIPEN.
Patient received vaccine 07:52 am at 08:11 am he reported hand tingling, we noticed some swelling to left hand. BP 143/94 sat 99% P-81, patient initially declined going to ER, administered Benadryl 25 mg by mouth per protocol at 08:21 am, repeat BP 08:23 139/96 P-84, sat 98%, 08:42 BP 141/97, P-92,  sat 99%, 0843 noticed rash left forearm (not sure if there before) noticed after removing watch, patient agreed to Emergency Room check in, while waiting for ER check in patient had increased swelling, spread to forearm, notified ER intake nurse and transferred care to Emergency Room
1/9/22-Symptoms started 12/30/21. 3 other members in family tested +covid.Pt had a home/rapid POSITIVE covid test yesterday 1/8/22 - most symptoms are starting to improve, but cough is not improving.Covid vax x 2 and booster 10/2021Review of Systems. Constitutional: Positive for fatigue. Negative for chills, diaphoresis, fever and weight loss. HENT: Positive for rhinorrhea, sinus pressure and sore throat. Negative for ear pain, sinus pain, sneezing and trouble swallowing.   Respiratory: Positive for cough. Negative for hemoptysis, chest tightness, shortness of breath, wheezing and stridor. Cardiovascular: Negative for chest pain.
Information has been received from a pharmacist concerning a patient who on 03-FEB-2010 was intramuscularly vaccinated in the deltoid muscle with a dose of PNEUMOVAX 23. The pharmacist reported that some time after received the PNEUMOVAX 23, the patient experienced large area of swelling and induration at the injection site in the deltoid muscle. The patient sought unspecified medical attention. At the time of the report, the patient had not recovered. Additional information has been requested.
ADULT OBSTRUCTIVE SLEEP APNEA, MODERATE ACUTE NON ST ELEVATION MI ACUTE MI 10/24/2022 -- RECURRENCE OF SAME SYMPTOMS
Patient developed hard knot at injection site which spread across whole upper arm.  She also developed a red rash localized to injection site area.
Pt. had a slight fever - day after inj. put that is gone - no other symptoms.
5/8/2000 Emergency Room and Doctor Visit High Fever High Pitched Screaming Vomiting Lethargic No Appetite Viral Syndrome Diagnosis Spitting Up Breast Milk Real Sensitive To Noise  6/30/2000 Doctor Visit High Fever High Pitched Screaming Lethargic Cranky Croupy Rattling In Chest Hoarse Spitting Up Breast Milk
2 days after receiving subcutaneous injection patient felt fatigued x 1 week, along with headache.